Standout Papers

Antitumor Activity of the Glutaminase Inhibitor CB-839 in Tr... 2007 2026 2013 2019 772
  1. Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer (2014)
    Matt I. Gross, Susan D. Demo et al. Molecular Cancer Therapeutics
  2. Antitumor Activity of PR-171, a Novel Irreversible Inhibitor of the Proteasome (2007)
    Susan D. Demo, Christopher J. Kirk et al. Cancer Research

Immediate Impact

4 by Nobel laureates 19 from Science/Nature 71 standout
Sub-graph 1 of 23

Citing Papers

Arginine reprograms metabolism in liver cancer via RBM39
2023 Standout
Pancreatic cancer: Advances and challenges
2023 Standout
8 intermediate papers

Works of Guy J. Laidig being referenced

Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer
2014 Standout

Author Peers

Author Last Decade Papers Cites
Guy J. Laidig 1025 345 277 639 9 1.3k
Jinfu Yang 753 207 155 648 12 1.1k
Peter J. Shwonek 987 304 68 670 9 1.5k
Alexandra Grassian 1231 361 80 787 17 1.7k
Chiara Balestrieri 721 250 81 491 19 1.0k
Biniam Adane 1065 186 737 577 22 1.5k
Dean C. Singleton 1012 268 202 356 24 1.5k
Nabilah Khan 865 164 684 452 17 1.3k
Borys Korchin 605 235 143 408 18 1.1k
C. A. Griffin 471 353 129 323 14 1.0k
Max Hamaker 784 110 50 711 9 1.1k

All Works

Loading papers...

Rankless by CCL
2026